A Case of Crohn's Disease with Improvement after Azathioprine-Induced Pancytopenia

The immunosuppressant azathioprine (AZA) is widely used in the treatment of inflammatory bowel disease (IBD) for both inducing and maintaining remission. However, the adverse effects of AZA can often necessitate a dose reduction or discontinuation. Bone marrow suppression is one of the most serious...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yong Sung, Suh, Jung Pil, Song, Kee Ho, Lee, Jae Bum, Lee, Doo Seok, Lee, In Taek, Kim, Do Sun, Lee, Doo Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Published Online: July 2011
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134056/
https://www.ncbi.nlm.nih.gov/pubmed/21769285
http://dx.doi.org/10.1159/000329707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134056/
https://www.ncbi.nlm.nih.gov/pubmed/21769285
http://dx.doi.org/10.1159/000329707

Ejemplares similares